CellScape™ XR Platform
High fidelity, flexible subcellular proteomics for rapid and quantitative spatial phenotyping

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The CellScape XR platform delivers quantitative subcellular spatial proteomics for rigorous, reproducible spatial phenotyping across the full research-to-translation continuum. Best-in-class resolution, high dynamic range, and whole-slide imaging enable confident single-cell phenotype discovery, validation, and clinical-grade characterization within intact tissue. An open, flexible assay ecosystem, built on gentle EpicIF signal removal and 6,000+ off-the-shelf, directly conjugated antibodies, lets researchers design panels around their biology rather than platform constraints, while automated cyclic workflows scale that quantitative performance across large cohorts and multiple tissue types without compromising data quality.
Key Benefits:
- Differentially Quantitative Phenotyping: Best-in-class resolution and high dynamic range for differentially quantitative spatial phenotyping
- Robustness and Flexibility: Gentle signal removal compatible with virtually any antibody for rapid panel development
- High Throughput: Scalable whole-slide imaging
Key Applications:
- Tumor Microenvironment Characterization
- Immune Profiling and Immuno-oncology
- Neuroscience and Neurodegenerative Disease Research
- Infectious Disease Studies
- Translational Biomarker Research
Learn More
Contact a Bruker Spatial Biology specialist to explore how the CellScape Precise Spatial Proteomics platform can support your spatial biology workflows.
Brochures
Precise spatial proteomics with the CellScape Platform
Explore the CellScape™ platform from Bruker Spatial Biology – an end-to-end solution for highly multiplexed spatial proteomics and single-cell analysis.* With an advanced imaging system, streamlined fluidics for walk-away automation, and unprecedented flexibility in assay design, the CellScape platform accelerates biological research from discovery to translation.
*For research use only. Not for use in diagnostic procedures.
Ultra-high-plex immunofluorescence analysis of the tumor-immune microenvironment with EpicIF on the CellScape platform
Bruker presents research demonstrating ultra-high-plex immunofluorescence analysis of the tumor–immune microenvironment using EpicIF™ Technology with CellScape™ XR Platform. The workflow combines iterative staining and imaging to generate highly multiplexed spatial biology data, enabling profiling of up to 208 antibodies on a single tissue section.
The poster highlights applications in tumor microenvironment characterization, immune cell phenotyping, spatial proteomics, tissue segmentation, and large-scale cohort analysis. Results suggest the platform can support high-resolution spatial mapping of cellular populations and biomarker expression while enabling efficient screening of complex tissue samples.
Resource details:
Resource type: Scientific poster
Page count: 1
Read time: 2 mins
Expandable immunofluorescence assays with next-generation VistaPlex immune profiling kits
VistaPlex assay kits are modular, ready-to-use multiplex immunofluorescence (mIF) assays designed to deliver comprehensive cellular phenotyping and spatial tissue insights for advanced spatial biology applications. Enhanced by EpicIF technology, the CellScape Precise Spatial Proteomics platform now supports expanded multiplex dye compatibility, ensuring that next-generation VistaPlex kits integrate seamlessly with the EpicIF workflow. Data presented highlight the effectiveness of the Segmentation, Spatial Immune Profiling, and Architecture panels across a wide array of human FFPE tissues, revealing distinct biological insights achievable with individual kits or combined panel configurations.
VistaPlex immunofluorescence assay panels
VistaPlex Spatial Immune and Architecture Kits for spatial analysis on human formaldehyde-fixed, paraffin-embedded (FFPE) tissues enable the profiling of immune populations and tissue architecture using validated antibodies and optimized staining protocols. Canopy Biosciences details a study which compares the efficiency of different assay kits and highlights their ability to identify various cellular phenotypes across different tissue types and disease states. Further, Canopy Biosciences emphasizes the compatibility of VistaPlex kits with CellScape Whole-Slide Imaging Chambers, enhancing the reproducibility and utility of the assays in basic and translational research settings. Overall, VistaPlex kits offer a robust and cost-effective solution for spatial biology research, facilitating deep phenotyping of immune and cancer cells in diverse tissues.
Precise spatial multiplexing of protein biomarkers for immune profiling in tissue samples with ChipCytometry
Immunohistochemistry is the most widely used diagnostic technique in tissue pathology. However, IHC is associated with several limitations including the labeling of just a few markers per tissue section and limited quantification of cell populations. As a result of plex limitations, key insights about tumor biology are missed, which could be important for advancing our understanding of tumor biology and ultimately improving patient outcomes. ChipCytometry™ is a novel image-based platform for precise spatial multiplexing that addresses these challenges by combining iterative immuno-fluorescent staining with high dynamic range imaging to facilitate quantitative phenotyping with single-cell resolution.
In this research poster, Canopy Biosciences demonstrates how standard flow cytometry standard (FCS) files are generated from multichannel OME-TIFF images, enabling the identification of cellular phenotypes via flow cytometry-like hierarchical gating. Quantification of results reveals precise expression levels for each marker in the assay in each individual cell in the sample, while maintaining spatial information about each cell.
Bruker Spatial Biology to announce groundbreaking advances at AGBT 2025
Advancements to include CosMx® Whole Transcriptome Panel; enhanced technology engine to power CellScape™ for spatial proteomics; expansion to 1000-plex protein assay on GeoMx® DSP; and launch of PaintScape™, a revolutionary platform enabling direct visualization of the 3D genome




















